Tools for Evaluating the Metropolitan Medical Response System Program: Phase I Report

by Institute of Medicine, Board on Health Sciences Policy, Committee on Evaluation of the Metropolitan Medical Response Program

The U.S. Department of Health and Human Services' Metropolitan Medical Response (MMRS) program has evolved from an idea originally developed in the Washington, D.C., area in 1995. Using the combined personnel and equipment resources from Washington, D.C., Arlington County in Virginia, and Montgomery and Prince Georges Counties in Maryland, the Metropolitan Medical Strike Team (MMST) received training, equipment, and supplies specifically designed to facilitate an effective response to a mass-casualty terrorism incident with a weapon of mass destruction (WMD). The first of its kind in the civilian environment, the MMST was intended to be capable of providing initial, on-site emergency health, medical, and mental health services after a terrorist incident involving chemical, biological, or radiological (CBR) materials. The team's mission includes CBR agent detection and identification, patient decontamination, triage and medical treatment, emergency transportation of patients to local hospitals, coordination of movement of patients to more distant hospitals via the National Disaster Medical System (NDMS), and planning for the disposition of nonsurvivors. Building from the initial efforts of the Washington, D.C., Metropolitan Area MMST, OEP provided funding for the development of a similar team in the city of Atlanta in preparation for the 1996 Summer Olympic Games. The U.S. Congress has subsequently authorized and provided funding for additional contracts with the 120 most populous U.S. cities. Tools for Evaluating the Metropolitan Medical REsponse System Phase I Report identifies and develops performance measures and systems to assess the effectiveness of, and to identify barriers related to, the MMRS development process. This report identifies, recommends, and develops performance measures and systems to assess the effectiveness of, and identify barriers related to, the MMRS development process at the site, jurisdictional, and governmental levels.

63 pages, Paperback

First published October 30, 2001

About the author

The National Academy of Medicine (NAM, formerly the Institute of Medicine-IOM) is an American nonprofit, non-governmental organization. The National Academy of Medicine is a part of the National Academies of Sciences, Engineering, and Medicine, along with the National Academy of Sciences (NAS), National Academy of Engineering (NAE), and the National Research Council (NRC).

The National Academy of Medicine provides national advice on issues relating to biomedical science, medicine, and health, and serves as an adviser to the nation to improve health aims to provide unbiased, evidence-based, and authoritative information and advice concerning health and science policy to policy-makers, professionals, leaders in every sector of society, and the public at large.

Operating outside the framework of the U.S. federal government, it relies on a volunteer workforce of scientists and other experts, operating under a formal peer-review system. As a national academy, new members of the organization are elected annually by current members, based on their distinguished and continuing achievements in a relevant field as well as for their willingness to participate actively.